drugset / Trial / NCT01426555
FES-Rowing Versus Zoledronic Acid to Improve Bone Health in Spinal Cord Injury (SCI)
Phase 2/3
Terminated
70 enrolled
Antonio Lazzari
Massachusetts General Hospital · collabSpaulding Rehabilitation Hospital · collabUnited States Department of Defense · collabVA Boston Healthcare System · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
This is a research study to determine the effects of functional electrical stimulation (FES) rowing and a drug called zoledronic acid in bone health. The investigators hoped to learn if zoledronic acid treatment will increase bone mineral density in persons with chronic spinal cord injury (SCI) who received it. The investigators also want to find out if zoledronic acid is safe for persons with SCI to take without causing too many side effects.
Timeline
- Start
- 2011-02
- Primary completion
- 2015-02
- Completion
- 2015-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Zoledronic acid | Other / unclassified | 5 mg | Intravenous |